EAM Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-58,631
Closed -$3.26M 336
2024
Q3
$3.26M Buy
+58,631
New +$3.26M 0.49% 108
2021
Q1
Sell
-19,046
Closed -$2.64M 424
2020
Q4
$2.64M Buy
19,046
+1,858
+11% +$257K 0.43% 56
2020
Q3
$1.41M Buy
+17,188
New +$1.41M 0.34% 123
2014
Q4
Sell
-26,186
Closed -$1.48M 347
2014
Q3
$1.48M Buy
+26,186
New +$1.48M 0.3% 139